| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/26/2002 | US20020197307 Containing venlafaxine hydrochloride; side effect reduction |
| 12/26/2002 | US20020197306 Cationic lipid compositions targeting angiogenic endothelial cells |
| 12/26/2002 | US20020197304 Compositions for the treatment and prevention of cancer |
| 12/26/2002 | US20020197303 Microbiocide, antipyretics using flower extract |
| 12/26/2002 | US20020197300 Drug delivery system for anti-glaucomatous medication |
| 12/26/2002 | US20020197298 Interior core in well containing active materials; aperture to exterior |
| 12/26/2002 | US20020197288 Topical applying; mixture of fibers and ubiquinone |
| 12/26/2002 | US20020197285 Diesters or polyesters of naphthalene dicarboxylic acid as solubilizer/stabilizer for retinoids |
| 12/26/2002 | US20020197284 Transdermal and topical administration of local anesthetic agents using basic enhancers |
| 12/26/2002 | US20020197283 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 12/26/2002 | US20020197267 Integrin binding motif containing peptides and methods of treating skeletal diseases |
| 12/26/2002 | US20020197246 Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
| 12/26/2002 | US20020197236 Treatment of deseases by site specific instillation of cells or sitespecific transformation of cells and kits therefor |
| 12/26/2002 | US20020197235 Method for short-term and long-term drug dosimetry |
| 12/26/2002 | US20020197220 Composition comprising at least one liquid fatty phase structured by at least one semi-crystalline polymer |
| 12/26/2002 | US20020197212 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis |
| 12/26/2002 | US20020197210 Stabilized therapeutic and imaging agents |
| 12/26/2002 | US20020197207 Radionuclide-coated particulate material |
| 12/26/2002 | US20020197206 Mesoporous compositions and method of preparation |
| 12/26/2002 | US20020195452 Stackable low depth tray |
| 12/26/2002 | US20020195100 Vaporizing device for administering sterile medication |
| 12/26/2002 | US20020195053 Dry powder electrostatic deposition method and apparatus |
| 12/26/2002 | US20020194780 Cultivated agarwood |
| 12/25/2002 | CN1387577A Process for producing product contg. antihypertensive tripeptides |
| 12/25/2002 | CN1387564A Lactobacillus helvetius producing antihypertensive di- and tripeptides |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1387503A Hydroxyeicosatetraenoate salts, composition and method of use in treating dry eye disorders |
| 12/25/2002 | CN1387438A 联合化学疗法 Combined chemotherapy |
| 12/25/2002 | CN1387436A Preventive and therapeutic agents for eye diseases |
| 12/25/2002 | CN1387435A Lipoxin A4 and its analogs for treatment of dry eye |
| 12/25/2002 | CN1387433A Method for administering phosphodiesterase 4 inhibitor |
| 12/25/2002 | CN1387431A Combination comprising beta 2 adranoreceptor agonist and lenkotriene receptor antagonist |
| 12/25/2002 | CN1387430A Liver selective therapy |
| 12/25/2002 | CN1387428A Sustained-release drug formulations for implantation |
| 12/25/2002 | CN1386520A Chinese medicine composition for treating acute mastitis, mastroplasia and hysteromyoma |
| 12/25/2002 | CN1386513A Ointment for treating burn and scald and its preparing process |
| 12/25/2002 | CN1386506A Sulfamine ointment |
| 12/25/2002 | CN1386498A PH-dependent slow-release preparation for Chinese medicine and its preparing process |
| 12/25/2002 | CN1386497A Alpha-linolenic acid microcapsule and its preparing process |
| 12/25/2002 | CN1386496A Coating technique for artemisia pigweed preparation |
| 12/25/2002 | CN1386495A Process for preparing superfine particles of Chinese medicine |
| 12/25/2002 | CN1096886C Milling process for production of finely milled medicinal substances |
| 12/25/2002 | CN1096870C Topical dressing device and method of mfg. same |
| 12/25/2002 | CN1096869C Sustained release formulation of animal growth hormone and process for preparation thereof |
| 12/25/2002 | CN1096868C Medical paste for treating cancer |
| 12/25/2002 | CN1096864C Active royal jelly lozenge and method for preparing same |
| 12/25/2002 | CN1096862C Controlled-release dosage form of azithromycin |
| 12/25/2002 | CN1096858C Gepirone dosage form |
| 12/25/2002 | CN1096857C Iontophoretic delivery of antimigraine drug |
| 12/25/2002 | CN1096852C Resina Draconis preparation as Chinese medicine and its preparation process |
| 12/25/2002 | CN1096851C Adjuvant for vaccine compsoition |
| 12/25/2002 | CN1096850C Preparation of multivesicular liposomes for controlled release of active agent |
| 12/25/2002 | CN1096843C Cosmatic and/or dermal composition contg. salicyclic acid |
| 12/24/2002 | US6498153 Extended release growth promoting two component composition |
| 12/24/2002 | US6498152 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis |
| 12/24/2002 | US6497949 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives |
| 12/24/2002 | US6497906 Anticholesterol, reduced menstrual bleeding |
| 12/24/2002 | US6497905 Aqueous solubility pharmaceutical formulations |
| 12/24/2002 | US6497904 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent |
| 12/24/2002 | US6497903 Hydrolysable hydrogels for controlled release |
| 12/24/2002 | US6497902 Biocompatible adhesive or glue |
| 12/24/2002 | US6497901 Calcium sulfate |
| 12/24/2002 | US6497900 Gas generating tablet, grain; mixing, crystallizing mixture of sodium tartarate and sodium (bi)carbonate |
| 12/24/2002 | US6497899 Pharmaceutically acceptable steam extruded polymer, and medicament; rapid oral drug delivery or as vaginal or rectal suppositories or for oral delivery of veterinary drugs |
| 12/24/2002 | US6497898 Stability, drug and cosmetic delivery |
| 12/24/2002 | US6497897 For sustained releasing of durg for percutaneous administration |
| 12/24/2002 | US6497896 Aqueous suspension; thermal sterilization |
| 12/24/2002 | US6497895 Transdermal patch |
| 12/24/2002 | US6497891 Make-up compositions |
| 12/24/2002 | US6497890 Anti-wrinkle preparation and method of reducing wrinkles in facial skin and neck |
| 12/24/2002 | US6497887 Delivery system for topical application to skin comprising freeze-dried, partially crosslinked polymeric gel membrane containing hyaluronic acid as disrupting agent, which can be returned to dissolvable gel upon application of wetting agent |
| 12/24/2002 | US6497886 1,3-bis-(N-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 12/24/2002 | US6497869 Having a ph of 5.0 to 8.0, and a salt comprising sulfate ions; treatment of shipping fever, bovine mastitis |
| 12/24/2002 | US6497867 Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizers |
| 12/24/2002 | US6497699 Hybrid neuroprosthesis for the treatment of brain disorders |
| 12/24/2002 | US6497698 Method and apparatus for treating a patient |
| 12/24/2002 | CA2278802C Ophthalmic compositions including glycerin and propylene glycol |
| 12/24/2002 | CA2222133C Transdermal patch and method for administering 17-deacetyl norgestimate alone or in combination with an estrogen |
| 12/24/2002 | CA2172955C Liposomal defensins |
| 12/24/2002 | CA2134611C Process for preparing solid pharmaceutical dosage forms |
| 12/24/2002 | CA2093526C Method of making oil filled paucilamellar lipid vesicles |
| 12/24/2002 | CA2081070C Buoyant controlled release powder formulation |
| 12/24/2002 | CA2049973C Intralumenal drug eluting prosthesis |
| 12/22/2002 | CA2391078A1 Pharmaceutical compositions comprising drug and concentration-enhancing polymers |
| 12/21/2002 | CA2390757A1 Method of decreasing fasting sugars and weight gains in diabetic patients |
| 12/19/2002 | WO2002101412A2 Spray freeze-dried compositions |
| 12/19/2002 | WO2002101146A1 Luminous paper and production method thereof and utilization method thereof |
| 12/19/2002 | WO2002100996A1 Azeotrope-like compositions of tetrafluoroethane pentafluoropropane, methylbutane and water |
| 12/19/2002 | WO2002100890A2 Respiratory syncytial virus |
| 12/19/2002 | WO2002100879A1 Novel anti-inflammatory 17.alpha.-heterocyclic-esters of 17.beta.carbothioate androstane derivatives |
| 12/19/2002 | WO2002100877A1 Novel 2-alkoxyestradiol analogs with antiproliferative and antimitotic activity |
| 12/19/2002 | WO2002100862A2 Novel substituted tetracyclic imidazole derivatives, processes for their preparation, pharmaceutical compositions comprising them and their use as a medicine |
| 12/19/2002 | WO2002100628A1 Preservation of biological materials using fiber-forming techniques |
| 12/19/2002 | WO2002100548A2 Centrifuged rotating drum for treating cohesive powders |
| 12/19/2002 | WO2002100529A1 Unimolecular polymeric micelles with an ionizable inner core |
| 12/19/2002 | WO2002100506A1 Azeotrope-like compositions of tetrafluoroethane, pentafluoropropane and water |
| 12/19/2002 | WO2002100456A1 Using supercritical fluids to infuse therapeutic on a medical device |
| 12/19/2002 | WO2002100450A1 Self-adhesive matrix plaster containing an active ingredient and based on polyurethane gels |
| 12/19/2002 | WO2002100444A1 Colloidal metal labelled microparticles, their production and use |
| 12/19/2002 | WO2002100439A1 Water-soluble stabilized self-assembled polyelectrolytes |